Concourse Financial Group Securities, Inc. Bridge Bio Pharma, Inc. Call Options Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BBIO
# of Institutions
434Shares Held
189MCall Options Held
11.2MPut Options Held
1.95M-
Viking Global Investors LP18.6MShares$1.24 Billion2.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.8MShares$1.12 Billion0.01% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$883 Million22.63% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$829 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X09.28MShares$618 Million0.21% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $9.87B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...